No results, please enter a search term above
|Date of Alert|
|No Health Alerts Found|
|Acute Flaccid Myelitis: Recognition, Testing, and Reporting Requirements||Advisory||Dec 5, 2022|
|Acute Flaccid Myelitis: Clinical Reminders and Reporting Requirements||Advisory||Oct 3, 2018|
|Acute Flaccid Myelitis: Clinical Reminder and Reporting Requirements||Advisory||Sep 9, 2016|
|Acute Flaccid Myelitis: Identification, Testing, and Reporting Guidelines||Advisory||Sep 3, 2015|
CDC Acute Flaccid Myelitis Surveillance - Case Definition and AFM Cases and Outbreaks
National Library of Medicine's Current Treatments of Children with AFM
Because the pathogen responsible for causing acute flaccid myelitis (AFM) has not been identified no vaccine recommendations are available at this time.
If AFM is suspected, specimen collection should occur as early as possible, ideally on the day of limb weakness onset. Please call PDPH to coordinate testing of the following clinical specimens (in order of priority):
More information on specimen collection can be found at CDC’s AFM Specimen Collection page.
Click here for a CDC Job Aid for Clinicians on sending information on suspected AFM cases to the health department.
* Spinal cord lesions may not be present on initial MRI; a negative or normal MRI performed within the first 72 hours after onset of limb weakness does not rule out AFM. MRI studies performed 72 hours or more after onset should also be reviewed if available.
+ Terms in the spinal cord MRI report such as “affecting mostly gray matter,” “affecting the anterior horn or anterior horn cells,” “affecting the central cord,” “anterior myelitis,” or “poliomyelitis” would all be consistent with this terminology.
There are no patient or community resources for Acute Flaccid Myelitis.
There are no posters for Acute Flaccid Myelitis.